UT Health San Antonio news.uthscsa.edu

Owens Medical Research Foundation awards UT Health San Antonio investigators $1.5 million to advance Alzheimer’s and cancer research

news.uthscsa.edu·45w

Drug Target Review: Why PARP inhibitors fail: key role of the CST complex in BRCA1-deficient cancers

news.uthscsa.edu

·45w

Science Magazine: Innovative Urine-Based Tumor DNA Test Promises Personalized Bladder Cancer Therapy

news.uthscsa.edu

·45w

Medical Xpress: Urine-based tumor DNA test may help personalize bladder cancer treatment

news.uthscsa.edu·45w

MSN.com: Urine-based DNA test predicts bladder cancer recurrence after immunotherapy

news.uthscsa.edu

·45w

Bioengineer.org: Innovative Urine-Based Tumor DNA Test Promises Personalized Bladder Cancer Therapy

news.uthscsa.edu

·45w

News-Medical: Urine-based DNA test predicts bladder cancer recurrence after immunotherapy

news.uthscsa.edu·45w

WOAI TV (NEWS4SA): UT Health San Antonio receives $3.4M for cancer research and HPV vaccination efforts

news.uthscsa.edu

·45w

KABB-TV (Fox San Antonio): UT Health San Antonio receives $3.4M for cancer research and HPV vaccination efforts

news.uthscsa.edu

·45w

WOAI TV (NEWS4SA): UT Health San Antonio receives $3.4M for cancer research and HPV vaccination efforts

news.uthscsa.edu·45w

New urine-based tumor DNA test may help personalize bladder cancer treatment

news.uthscsa.edu·45w

New urine-based tumor DNA test may help personalize bladder cancer treatment

news.uthscsa.edu·45w

San Antonio Express-News: UT Health San Antonio awarded $3.4M for cancer research, HPV outreach

news.uthscsa.edu·46w

MHI director delivers keynote at graduation ceremony

news.uthscsa.edu·46w

Sara Gill named a UT System Distinguished Teaching Professor

news.uthscsa.edu·46w

Healthcare IT News: HIMSSCast: How an MD/MS in AI dual degree could change health IT leadership

news.uthscsa.edu

·46w

PipelineReview.com: Cirius Therapeutics Announces Positive Data for MPC Inhibitor 0602K Alone and in Combination with Tirzepatide

news.uthscsa.edu·46w

FirstWord Pharma: Cirius Therapeutics Announces Positive Data for MPC Inhibitor 0602K Alone and in Combination with Tirzepatide

news.uthscsa.edu

·46w

CancerNetwork: Rhenium Obisbemeda Shows No DLTs and Improves Survival in Recurrent Glioma

news.uthscsa.edu

·46w

A conversation about the shared vision for the future of the new, unified university

news.uthscsa.edu·46w

Log in to enable infinite scrolling